Popular films & media are littered with references to psychedelic use. These powerful compounds have been used for centuries, claiming to expand the mindnand calm the spirit. Indigenous people all over the globe have used psilocybin to treat everything from depression to migraines. But one question still remains: Can psychedelics improve our modern-day mental health?
To kickoff the 10th season of HBO's "Last Week Tonight with John Oliver," Oliver tackles the controversial topic of psychedelic-assisted therapy (Link Below). Psychedelics is a powerful class of drug that includes MDMA, LSD, and Psilocybin. Though the show takes several comedic jabs at the social-stigma that historically surrounds these compounds, John Oliver goes on to point out that the majority of studies have shown psychedelic-assisted therapy to be extremely effective. Often used to treat patients with challenging & chronic diagnoses such as PTSD, Depression, or even Substance Abuse, patients report a reduction in symptoms after just a single treatment. Those who completed lengthy treatment cycles report that Psychedelic-Assisted therapy drastically improved their symptoms for months and even years.
At Neuro-Behavioral Clinical Research, we are proud to be the first site in Ohio approved to conduct Psilocybin trials. Recruitment will begin in late 2023. Using state-of-the-art technology coupled with over 20 years of advanced clinical research methods, Dr. Shishuka Malhotra and her team of experts are a perfect choice to begin this crucial work. As Sponsors and CROs develop compounds that may improve mental wellness, Dr. Malhotra and the dedicated team at Neuro-Behavioral Clinical Research stand ready to collect impactful data that will improve the lives of our patients for years to come.
About the author: Molly Little is the Community Outreach Director for Neuro-Behavioral Research & Ohio Center for Hope. Molly is an advocate for LGBTQIA+ & other Minority Communities. She graduated from Miami University & originates from Ross, Ohio. For more on this article, contact Molly at MLittle@nb-cr.com
Comments